## Review setup
- **Input scope** Abstract
- **Assessment boundary** Claims and evidence presented in the abstract only
- **Shared manuscript claim summary** The authors present CDSM, a geometry-guided deterministic model for collagen triple-helix structure prediction, and claim it achieves high coverage (93.8% vs 8.8% for THeBuScr), competitive accuracy with learned models (AlphaFold 3, Boltz-2, Chai-1, Protenix-v1) on a benchmark of 80 structures, superior robustness on post-cutoff structures, and dramatically lower cost (400–790x cheaper, ~$3×10⁻⁵ per structure).
- **Visible evidence base** Abstract text only; no figures, tables, or supplementary materials provided.
- **Missing materials affecting confidence** Full manuscript, methods, benchmark details, statistical analyses, figure legends, and supplementary data are not available. The abstract provides summary statistics but no error bars, confidence intervals, or detailed comparisons.

## Reviewer
- **Overall assessment** The abstract presents a compelling and well-motivated case for a compact, geometry-based approach to collagen structure prediction. The reported coverage improvement and cost reduction are striking, and the post-cutoff analysis is a thoughtful test of generalizability. However, the abstract alone cannot substantiate several critical claims: the benchmark composition, the statistical significance of accuracy comparisons, the definition of "successful prediction," and the robustness of the cost analysis. The work is potentially important, but the evidence as presented is insufficient to fully evaluate its validity.

- **Who would be interested in the results, and why** Structural biologists, computational biophysicists, and researchers in protein design and biomaterials, particularly those working on fibrous proteins or systems with strong geometric constraints. The work also interests the broader AI-for-science community as a demonstration of compact, interpretable models complementing large learned ones.

- **Major strengths** 1. Clear motivation: collagen's constrained geometry is a natural fit for a compact model. 2. Impressive coverage improvement (8.8% to 93.8%) over the baseline THeBuScr. 3. Thoughtful evaluation design, including a post-cutoff subset to test generalizability. 4. Dramatic cost reduction (400–790x cheaper) is a strong practical advantage. 5. The broader message about compact scientific representations is timely and important.

- **Major Concerns**
    - **Concern ID** R1-M1
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Evidence completeness
    - **Claim pointer** "CDSM increases coverage of this benchmark from 8.8% for native THeBuScr to 93.8%."
    - **Evidence pointer** Abstract, location not provided
    - **Concern** The abstract does not define what constitutes a "successful prediction" (e.g., RMSD or TM-score threshold, or whether all-atom or backbone). Without this definition, the coverage metric is uninterpretable. Additionally, the benchmark of 80 structures is not described: are they all unique collagen sequences? What is the diversity of lengths, post-translational modifications, or resolution? The 8.8% baseline for THeBuScr is also unexplained—does THeBuScr fail on 91.2% of structures, or is it not designed for all-atom prediction?
    - **Why it matters** The central claim of the paper—that CDSM dramatically improves coverage—cannot be evaluated without knowing the success criteria and benchmark composition. If the threshold is too lenient, the coverage may be inflated; if the benchmark is biased, the comparison may be unfair.
    - **Resolution test** Provide a clear definition of "successful prediction" (e.g., backbone RMSD < 2 Å, TM-score > 0.8). Describe the benchmark: number of unique sequences, length range, resolution distribution, and any filtering criteria. Explain why THeBuScr achieves only 8.8% coverage.

    - **Concern ID** R1-M2
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Statistical rigor
    - **Claim pointer** "CDSM closely reproduces experimental backbone and global geometry, with fewer large-error predictions, while the learned models achieve modestly higher local and side-chain accuracy."
    - **Evidence pointer** Abstract, location not provided
    - **Concern** The abstract reports aggregate win rates (29% to 55% for TM-score, 40% to 65% for backbone RMSD) on post-cutoff subsets, but does not provide any measure of variance (e.g., standard deviation, confidence intervals, or per-structure distributions). The phrase "fewer large-error predictions" is qualitative. Without statistical testing, it is unclear whether the observed differences are significant or due to random variation across the small post-cutoff set.
    - **Why it matters** The claim that CDSM becomes "more competitive" on post-cutoff structures is a key argument for its robustness. If the win rates are not statistically significant, the conclusion is unsupported. Similarly, the trade-off between CDSM's global accuracy and learned models' local/side-chain accuracy needs quantitative comparison.
    - **Resolution test** Provide per-structure results (e.g., scatter plots of TM-score or RMSD for each method), report mean ± SD or 95% CI for all metrics, and perform a statistical test (e.g., paired t-test or Wilcoxon) comparing CDSM to each learned model on the post-cutoff subset.

    - **Concern ID** R1-M3
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Cost analysis validity
    - **Claim pointer** "CDSM generates structures in 2.4 s on a single CPU core at approximately $3 x 10^-5 per structure, making it 400 to 790x cheaper than the learned methods even when each is run on its lowest-cost compatible GPU."
    - **Evidence pointer** Abstract, location not provided
    - **Concern** The cost comparison is presented as a single number without accounting for hardware amortization, energy costs, or cloud pricing variability. The "lowest-cost compatible GPU" for each learned model is not specified, and the 400–790x range is not explained (e.g., what drives the lower vs. upper bound?). Additionally, the cost per structure for CDSM ($3×10⁻⁵) seems extremely low—is this purely compute cost, or does it include development/amortization? The abstract does not state whether the 2.4 s includes preprocessing or postprocessing.
    - **Why it matters** The cost advantage is a major selling point for practical applications. If the comparison is not apples-to-apples (e.g., ignoring GPU rental minimums or setup time), the claim may be misleading. A rigorous cost analysis is essential for reproducibility and fair comparison.
    - **Resolution test** Provide a detailed cost model: hardware specifications, cloud pricing source, runtime per structure (including any overhead), and the basis for the 400–790x range. Clarify whether costs are marginal (per-structure) or include fixed costs. Report the cost for each learned method individually.

- **Minor Comments**
    - **Concern ID** R1-m1
    - **Severity** Minor
    - **Axis** Clarity
    - **Affected element** Benchmark description
    - **Evidence pointer** Abstract, location not provided
    - **Issue** The abstract states "80 experimentally resolved collagen triple-helical structures" but does not specify the source (e.g., PDB IDs) or resolution range.
    - **Required correction** Add a brief description of the benchmark source and key characteristics (e.g., "80 structures from the Protein Data Bank, resolution ≤ 3.0 Å, lengths 100–300 residues").

    - **Concern ID** R1-m2
    - **Severity** Minor
    - **Axis** Terminology
    - **Affected element** "Aggregate win rates"
    - **Evidence pointer** Abstract, location not provided
    - **Issue** The term "aggregate win rates" is ambiguous: does it mean the fraction of structures where CDSM outperforms each learned model, or an average across all comparisons?
    - **Required correction** Define "win rate" explicitly (e.g., "the fraction of structures for which CDSM achieves a higher TM-score than the learned model").

    - **Concern ID** R1-m3
    - **Severity** Minor
    - **Axis** Reproducibility
    - **Affected element** "Training-data cutoff"
    - **Evidence pointer** Abstract, location not provided
    - **Issue** The abstract refers to "each learned model's training-data cutoff" but does not state the cutoff dates or how they were determined.
    - **Required correction** Provide the cutoff dates for each learned model (e.g., "AlphaFold 3: September 2021; Boltz-2: January 2022") and the number of post-cutoff structures.

- **Technical failings that need to be addressed before the case is established** R1-M1 (coverage definition and benchmark), R1-M2 (statistical rigor of accuracy comparison), R1-M3 (cost analysis validity). These three concerns are blocking because the core claims of coverage, accuracy, and cost cannot be evaluated from the abstract alone.

- **Assessment against Nature-style criteria**
    - **Originality**: High. The idea of using a compact, geometry-guided model for a constrained protein family is novel and contrasts with the dominant learned-model paradigm. The post-cutoff analysis is a clever test of generalizability.
    - **Scientific importance**: Potentially high. If validated, CDSM could provide a practical tool for collagen structure prediction and inspire similar approaches for other constrained protein families. The cost reduction is significant for high-throughput applications.
    - **Interdisciplinary readership**: Moderate to high. The work bridges structural biology, computational modeling, and AI-for-science, and the cost/accuracy trade-off is of interest to experimentalists and computationalists alike.
    - **Technical soundness**: Cannot be fully assessed from the abstract. The coverage and accuracy claims lack statistical rigor, and the cost analysis is insufficiently detailed. The approach itself is plausible, but the evidence is incomplete.
    - **Readability for nonspecialists**: Good. The abstract is well-written, with clear motivation and a logical flow. Technical terms (e.g., "TM-score," "backbone RMSD") are used appropriately but could benefit from brief definitions.

- **Recommendation posture** Currently not established from the provided evidence. The abstract presents an intriguing and potentially important result, but the lack of methodological detail, statistical rigor, and cost analysis transparency prevents a full evaluation. The work merits further review of the full manuscript, but the claims as stated cannot be accepted without substantial additional evidence.